Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

The purpose of this study is to see what effects, good and/or bad, proton radiation, and/or conventional radiation and hormonal therapy (if applicable), has on prostate cancer that has already returned or the risk of prostate cancer returning.

Trial Details

NCT ID
NCT00969111
Phase
NA
Sponsor
Proton Collaborative Group
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE
  • Proton (prostate bed) to 70.2 CGE
  • IMRT to 45 Gy; proton boost to prostate bed to 25.2 CGE
  • Proton to 66.6 CGE
Locations (sample)
  • Little Rock, Arkansas, United States|34.74648,-92.28959
  • Jacksonville, Florida, United States|30.33218,-81.65565
  • Warrenville, Illinois, United States|41.81781,-88.1734
  • Flint, Michigan, United States|43.01253,-83.68746
  • St Louis, Missouri, United States|38.62727,-90.19789

Key Eligibility Criteria

  • Prostate cancer treated primarily with open, laparoscopic or robotically assisted prostatectomy.
  • Maximum PSA value of 20 ng/ml.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →